Medicated-Assisted Treatment in Indiana

If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2019-03-01
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
The Center for Health Policy
Abstract

Opioid misuse and addiction continues to affect many Americans. Medication-assisted treatment (MAT) using methadone, buprenorphine, or extended-release naltrexone in combination with behavioral therapy is the most effective intervention for opioid use disorders (OUDs). Despite its effectiveness, methadone to treat OUDs is not widely available. Buprenorphine is more accessible, as it can be prescribed by medical doctors, nurse practitioners, and physician assistants who have received specialized training and obtained a waiver from the DEA. Naltrexone is a non-narcotic and can be prescribed by any healthcare professional who has prescription privileges.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Kooreman, H. (2019). "Medication-Assisted Treatment in Indiana". Published by The Center for Health Policy at the IU Richard M. Fairbanks School of Public Health, Indianapolis, IN.
ISSN
Publisher
Series/Report
19-H03;
Sponsorship
Major
Extent
Identifier
Relation
Journal
Source
Alternative Title
Type
Other
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Full Text Available at
This item is under embargo {{howLong}}